To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients
Clinical trial NCT04445714 · COMPLETED
Trial details
- NCT number
- NCT04445714
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-07
- Primary completion
- 2023-03-14
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.